Bioxyne (ASX:BXN) has announced that its wholly-owned subsidiary, Breathe Life Sciences, has manufactured and delivered Australia’s first pharmaceutical-grade cannabis pastilles under its Good Manufacturing Practice (GMP) certification from the TGA. …
Bioxyne delivers Australia’s first pharmaceutical cannabis pastilles
August 21, 2024 Australian Biotech
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - Series 5. Ep.30
August 28, 2026 - - Podcast -
Sandoz earns workplace recognition amid push for medicine access
August 28, 2026 - - Latest News -
Cheaper medicines save Australians $1.4 billion as pharmacists urge freeze for all patients
August 28, 2026 - - Latest News -
Mayne Pharma bets on women’s health and direct distribution after a difficult year
August 28, 2026 - - Latest News -
Patients Australia puts healthcare’s quiet achievers in the spotlight
August 28, 2026 - - Latest News -
Weight loss medicines drive revenue growth for Sigma and Wesfarmers Health
August 28, 2026 - - BioPharma -
Cathy Freeman to headline 2026 Patient’s Choice Awards
August 27, 2026 - - Latest News